To investigate whether ALDH1A1 contributes to tumor immune evasion by elevating the glycolytic activity of tumor cells within an intact immune system, a xenograft model was established in normal immune BALB/c mice using CT26 cells that overexpress Aldh1a1. This evidence concerns the gene ALDH1A1 and neoplasm.